Ergoteles’s AB InBev BUD Stock Holding History

Ergoteles’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,972	Closed	-$360K	–	1474
2022 Q3	$360K	Buy	7,972 +1,207	+18%	+$62.5K	0.01%	892
2022 Q2	$365K	Buy	+6,765	New	+$380K	0.01%	1001

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ergoteles's BUD Position: Q4 2022 in Review

Ergoteles sold out of AB InBev (BUD) in Q4 2022, closing a stake of 7,972 shares — an estimated $360K sold.

Ergoteles first reported a position in BUD in Q2 2022 and held it in 2 quarters. The position peaked at $365K in Q2 2022. 510 funds tracked by Wall St. Rank hold BUD as of Q4 2022.

Ergoteles reported no remaining AB InBev position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 7,972 AB InBev shares in Q4 2022, an estimated $360K.
Ergoteles first reported a position in AB InBev in Q2 2022 and held it in 2 quarters.
Ergoteles's AB InBev position peaked at $365K in Q2 2022.
510 funds tracked by Wall St. Rank held AB InBev as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.